LAMP1 and COVID-19: The increased activation and cytotoxic phenotype in T cells from individuals with COVID-19 was functionally validated by flow cytometry analysis of PBMCs stimulated ex vivo with SARS-CoV-2 peptide showing upregulation of CD137 and CD107α (Extended Data Fig. 5f).